Neutrophil/Lymphocyte Ratio and All-Cause Mortality in Diabetic Kidney Disease: A Retrospective Cohort Study

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Dec 16

PMID 39677293

Authors

Yihua Bai

Lilan Huang

Yanqin Li

Shiyu Zhou

Luohua Li

Hongying Jiang

Sheng Nie

Zhijian Feng

Licong Su

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic kidney disease (DKD) is a significant contributor to the development of end-stage renal disease and cardiovascular disease (CVD), with inflammation being a critical factor in its pathogenesis. The aim of this study is to examine the relationship between the neutrophil-to-lymphocyte ratio (NLR), a new inflammatory marker, and mortality from all causes and CVD in patients with DKD.

Methods: This multicenter, retrospective cohort study utilized data from the China Renal Data System (CRDS) on patients with DKD hospitalized between January 1, 2000, and February 28, 2023. The patients' demographic information, along with their initial clinical and laboratory results, were collected and recorded. Follow-up continued until July 1, 2023, and patients were categorized into two groups based on the median baseline NLR. The Cox proportional hazards regression, Restricted cubic spline (RCS) curves, The Kaplan-Meier curve, Fine-Gray competing risk model, Time-dependent ROC and subgroup analysis were used to analyze the association between all-cause mortality and CVD mortality in patients having DKD with varying NLR.

Results: This study included 11,427 patients who had been clinically diagnosed with DKD. Baseline NLR was associated with C-reactive protein, procalcitonin, high-sensitivity C-reactive protein, plasma D-dimer, cystatin C, creatinine, urea nitrogen, brain natriuretic peptide, and eGFR. We selected the demographic characteristics, differential factors from univariate analysis, and clinically DKD-related laboratory indicators as covariates for Cox analysis. Results indicated that NLR was an independent risk factor for both all-cause and CVD mortality after adjusting for the relevant variables. The risk of all-cause death and CVD death in the high NLR group was 4.688 and 2.141 times higher, respectively, compared to the low NLR group (HR = 4.688, 95% CI 1.153-19.061, P = 0.031; HR = 2.141, 95% CI 1.257-3.644, P = 0.005). However, potential confounding factors and biases, such as unmeasured variables and the influence of treatment interventions, could not be fully accounted for.

Conclusion: NLR can independently predict the risk of all-cause and CVD mortality in patients with DKD. Identifying individuals with a high NLR and providing further intervention could be crucial measures to reduce both all-cause and CVD mortality. However, the results should be interpreted with caution due to the study's limitations.

References

Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi A . Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. J Immunother Cancer. 2018; 6(1):74. PMC: 6048712. DOI: 10.1186/s40425-018-0383-1. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View

Wang Z, Chen Z, Wang X, Hu Y, Kong J, Lai J . Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis the NF-κB signaling pathway. Front Pharmacol. 2022; 13:953004. PMC: 9426375. DOI: 10.3389/fphar.2022.953004. View

. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S):S1-S127. DOI: 10.1016/j.kint.2022.06.008. View

Wu H, Humphreys B . Immune cell heterogeneity in a mouse model of diabetic kidney disease. Kidney Int. 2022; 102(6):1215-1216. DOI: 10.1016/j.kint.2022.09.007. View

Huang M, Wei R, Wang Y, Su T, Di P, Li Q . Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ Open. 2017; 7(5):e014294. PMC: 5541338. DOI: 10.1136/bmjopen-2016-014294. View

Fest J, Ruiter R, Ikram M, Voortman T, van Eijck C, Stricker B . Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018; 8(1):10566. PMC: 6043609. DOI: 10.1038/s41598-018-28646-w. View

Zhu Y, Li G, Laukkanen J, Song X, Zhang J, Wei L . Higher neutrophil to lymphocyte ratio is associated with renal dysfunction and cardiac adverse remodeling in elderly with metabolic syndrome. Front Cardiovasc Med. 2022; 9:921204. PMC: 9492939. DOI: 10.3389/fcvm.2022.921204. View

Niewczas M, Pavkov M, Skupien J, Smiles A, Md Dom Z, Wilson J . A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat Med. 2019; 25(5):805-813. PMC: 6508971. DOI: 10.1038/s41591-019-0415-5. View

10.

Jiang G, Luk A, Tam C, Xie F, Carstensen B, Lau E . Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes. Kidney Int. 2018; 95(1):178-187. DOI: 10.1016/j.kint.2018.08.026. View

11.

Demir Y, Tokali F, Kalay E, Turkes C, Tokali P, Aslan O . Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors. Mol Divers. 2022; 27(4):1713-1733. DOI: 10.1007/s11030-022-10526-1. View

12.

Rizzoni D, De Ciuceis C, Szczepaniak P, Paradis P, Schiffrin E, Guzik T . Immune System and Microvascular Remodeling in Humans. Hypertension. 2022; 79(4):691-705. DOI: 10.1161/HYPERTENSIONAHA.121.17955. View

13.

Wilson P, Wu H, Kirita Y, Uchimura K, Ledru N, Rennke H . The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A. 2019; 116(39):19619-19625. PMC: 6765272. DOI: 10.1073/pnas.1908706116. View

14.

Sapa H, Gutierrez O, Shlipak M, Katz R, Ix J, Sarnak M . Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease. Am J Kidney Dis. 2022; 80(4):502-512.e1. PMC: 9554797. DOI: 10.1053/j.ajkd.2022.02.016. View

15.

Provenzano M, Maritati F, Abenavoli C, Bini C, Corradetti V, La Manna G . Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease. Int J Mol Sci. 2022; 23(10). PMC: 9144494. DOI: 10.3390/ijms23105719. View

16.

Rayego-Mateos S, Rodrigues-Diez R, Fernandez-Fernandez B, Mora-Fernandez C, Marchant V, Donate-Correa J . Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2022; 103(2):282-296. DOI: 10.1016/j.kint.2022.10.030. View

17.

Lee J, Kim N, Na S, Youn Y, Shin C . Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine (Baltimore). 2018; 97(26):e11138. PMC: 6039688. DOI: 10.1097/MD.0000000000011138. View

18.

Glemain A, Neel M, Neel A, Andre-Gregoire G, Gavard J, Martinet B . Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs. J Autoimmun. 2022; 129:102826. DOI: 10.1016/j.jaut.2022.102826. View

19.

Wen C, Chang C, Tsai M, Lee J, Lu P, Tsai S . Diabetes with early kidney involvement may shorten life expectancy by 16 years. Kidney Int. 2017; 92(2):388-396. DOI: 10.1016/j.kint.2017.01.030. View

20.

Fest J, Ruiter T, Groot Koerkamp B, Rizopoulos D, Ikram M, van Eijck C . The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study. Eur J Epidemiol. 2018; 34(5):463-470. PMC: 6456469. DOI: 10.1007/s10654-018-0472-y. View